Switch to Dark

Pricing

Learn

RMD - Resmed Inc

362

$227.88

-$5.62 (-2.407%)

At market close

$227.17

-$0.72 (-0.314%)

After Hours 3/18/26, 11:37 PM

Score

4.12/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

RMD

Valuation Score

View as %

Stock Unlock

YTD

Max

Key Data & Metrics

Market Cap

$33.20B

Industry

Health Care

EPS (TTM)

$10.15

P/E (TTM)

22.34

Div & Yield

$2.40 (1.05%)

FCF Payout Ratio

19.68%

P/S (TTM)

6.15

P/B

5.25

Diluted Shares

146.37M

Ex-Dividend

2026-02-12

Next Earnings

04-21

Forward P/E

19.57

Payout Ratio

23.53%

P/FCF (TTM)

18.69

FCF Yield

5.35%

Earnings Yield

4.48%

52 Week Range

Score Card

Explore Scores Tab

4.12

Good

Resmed Inc has grown revenue at 9.57% over the past year, which suggests sales are increasing. Also, it has more cash than current liabilities meaning it has enough cash to handle all its debts within the next year, if it wanted to.

Valuation Model

Key Score

1.00

Very Bad

Management

3.00

Average

Growth

3.00

Average

Profitability

5.00

Very Good

Fin. Health

4.00

Good

Dividends

4.00

Good

Analyst

4.00

Good

Insider Transactions

Explore Insider Tab

Buy

Sell

Market News

Page 1 of 21

Filter Form Types

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-11 08:29:35

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-03-09 11:24:50

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-05 14:51:36

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-03-04 18:23:09

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-03 16:29:56

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-03-02 11:41:45

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-02-10 13:33:22

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-02-09 16:17:02

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-02-06 11:07:47

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-02-06 11:05:33

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-02-04 18:53:01

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-02-04 10:59:20

Page 1 of 21

Financials

Explore Financials Tab

Revenue

Earnings

Free Cash Flow

Price Targets

Go to Analyst Tab

These are one year price targets for: 2027-02-21

High:

$362.25

59.0%

Avg:

$303.44

33.2%

Low:

$232.30

1.9%

(% change is relative to the current stock price: $227.88)

Analyst Recommendations

Go to Analyst Tab

3.72

Good

16%

Strong Buy (4)

48%

Buy (12)

32%

Hold (8)

Sell (0)

Strong Sell (1)

About

Website
https://www.resmed.com/
Address
9001 Spectrum Center Blvd, San Diego CALIFORNIA, US
SEC Reports
https://sec.gov/edgar/browse/?CIK=943819

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 10,600 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.

IPO Date

1995-06-01

Industry

Health Care

Total Employees

9,980

Exchange

New York Stock Exchange, Inc.

Reporting Currency

USD

GICS

Health Care Equipment & Supplies

GICS Sub

Health Care Equipment

GICS Sector

Health Care

GICS Group

Health Care Equipment & Services

Switch to Dark

Pricing

Learn

RMD - Resmed Inc

362

$227.88

-$5.62 (-2.407%)

$227.17

-$0.72 (-0.314%)

4.12/5

Stock Unlock

Key Data & Metrics

Score Card

Good

Insider Transactions

Market News

Form 4

Filed on 2026-03-11 08:29:35

Form 144

Filed on 2026-03-09 11:24:50

Form 4

Filed on 2026-03-05 14:51:36

Form 144

Filed on 2026-03-04 18:23:09

Form 4

Filed on 2026-03-03 16:29:56

Form 144

Filed on 2026-03-02 11:41:45

Form 4

Filed on 2026-02-10 13:33:22

Form 144

Filed on 2026-02-09 16:17:02

Form 4

Filed on 2026-02-06 11:07:47

Form 4

Filed on 2026-02-06 11:05:33

Form 144

Filed on 2026-02-04 18:53:01

Form 144

Filed on 2026-02-04 10:59:20

Financials

Price Targets

59.0%

33.2%

1.9%

Analyst Recommendations

About

Similar Stocks